Research carried out by IDIBELL and ICO within the framework of the European EPIC study, which includes the monitoring of more than 350,000 women for 15 years, has determined the inflammatory potential of their diets with a new scoring system.
The Mutua Madrileña Foundation today gave its XVII Grants for Health Research to 27 research projects throughout Spain, 5 of them in Catalonia, of which 2 have been awarded to IDIBELL researchers.
Thanks to this new tool, it will be possible to determine more precisely the indication for an implantable defibrillator for high-risk patients
The Research Conference of the Catalan Health Institute 2020-2021, held today, June 28, has distinguished Dr. Jordi Adamuz with the ICS 2021 Nurse Research Career Award, endowed with € 10,000. Adamuz is a principal investigator at the IDIBELL nursing research group, and is currently a referral nurse in the Information Systems Support Unit of the Bellvitge University Hospital, and a research support nurse at the same institution.
Vacunacció, the new initiative of the Escolab program with IDIBELL and the Virolai school, has ended this June with very original proposals.
The UICEC of IDIBELL is functionally dependent on the Clinical Pharmacology Service of the Bellvitge University Hospital and led by Dr. Pilar Hereu
The research projects have been performed by high school students from the Bellvitge and Mercè Rodoreda Institutes
The Bellvitge Institute, with whom IDIBELL has an educational Tandem, receives an honorable mention in the framework of the Conference
The promoter group works on the consolidation and empowerment of the biosanitary hub of L’Hospitalet and Esplugues de Llobregat. The project will be presented to the European recovery funds Next Generation.
This collaboration project between ICO, IDIBELL and the University of Barcelona (UB) has resulted in the ICOnnecta’t platform.
The study, published on Cell & Bioscience, includes two experimental approaches, one with mice and the other one with cell cultures. This discovery may be the basis for the development of better treatments for this disease and means a paradigm shift.
